arrow
T

Takashi Iwanaga

osaka saiseikai tondabayashi hospital
H指数:33
被引数:3,475

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of Easier Biologic Access with Remission and Other Clinical Outcomes in Severe Asthma: A Global Real-World Study

易得生物制剂与重症哮喘缓解及其他临床结局的关联:一项全球真实世界研究

2026-08-060
OA
Response to biologics along a gradient of T2 involvement in patients with severe asthma: a data-driven biomarker clustering approach

对重度哮喘患者T2炎症程度梯度下生物制剂应答的研究:一种数据驱动的生物标志物聚类方法

2025-09-020
OAAI
Prediction Pathway for Severe Asthma Exacerbations

严重哮喘急性发作的预测通路

CHEST
IF8.6
2025-05-190
OA
Impact of Biologics Initiation on Oral Corticosteroid Use in the International Severe Asthma Registry and the Optimum Patient Care Research Database: A Pooled Analysis of Real-World Data

生物制剂启动对口服糖皮质激素使用的影响:国际重症哮喘注册登记研究与国际患者护理研究数据库的真实世界数据合并分析

2025-04-260
OAAI
Phenotype and biomarkers in patients who initiated biologics therapy stratified by oral corticosteroid use in the International Severe Asthma Registry
2024-10-300
PRE
Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults

成人重症哮喘生物治疗后临床缓解的定义和预测因素探讨

2024-10-018
OAAI
Exploring Definitions and Predictors of Response to Biologics for Severe Asthma
2024-09-018
OAAI
International Variation in Severe Exacerbation Rates in Patients With Severe Asthma
CHEST
IF8.6
2024-07-013
PRE
Real-world biologics response and super-response in the International Severe Asthma Registry cohort

国际重症哮喘登记队列中的真实世界生物制剂反应和超反应

2024-06-220
OAAI
Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma

重症哮喘患者的前生物T2-biomarker组合与对生物制剂的反应之间的关联

2024-04-196
OAAI
Reply to Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry
2024-02-010
OAAI
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma
2024-02-0112
OA
Real-world associations between outcomes and biomarkers in severe asthma patients treated with biologics
2023-10-270
PRE
Clinical remission following biologic initiation in severe asthma: results of the International Severe Asthma Registry (ISAR)

重症哮喘患者开始生物治疗后的临床缓解: 国际重症哮喘注册中心 (ISAR) 的结果

2023-10-273
PRE
Real world biologic treatment response in severe asthma: an analysis of the International Severe Asthma Registry (ISAR)

重症哮喘的真实世界生物治疗反应: 对国际重症哮喘注册中心 (ISAR) 的分析

2023-10-270
PRE
Characteristics associated with clinical remission in patients with severe asthma who initiate biologics
2023-10-273
PRE